Retina Today

Featured

Complex Myopic MHRD: Membranes and Transplants

In the last installment of this three-part series, we describe the latest techniques for managing challenging retinal detachments.

Carlos Mateo, MD, and Anniken Burés-Jelstrup, MD

Extended ILM Peeling for PVR

This technique can help prevent recurrent retinal detachment by completely removing traction and the scaffold for reproliferation.

Taku Wakabayashi, MD, PhD, and Yoshihiro Yonekawa, MD

Imaging Epiretinal Proliferation Using OCT

En face OCT–based identification of proliferative changes may guide surgical strategies in full-thickness macular holes.

Kotaro Tsuboi, MD

OR Tech Update: 3D Displays, AI, and Robotics

New visualization tools are expanding what’s possible in the OR.

Kareena Chawla, BS; Jayanth Sridhar, MD; and Prashant D. Tailor, MD

Featured Supplements

Business Matters: When and How To Hire

Editorially independent content supported with advertising by EyePoint

Understanding Fast Progression in Geographic Atrophy

Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence

Editorially Independent Content, Supported With Advertising From Astellas

One to Watch: Samir N. Patel, MD

Editorially independent supported by Abbvie and Regenxbio

Rising Stars in Retina: Prashant D. Tailor, MD

Editorially independent supported by Abbvie and Regenxbio

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

Resources

April 2026

April 2026 | Features

Clinical Applications of Microscope-Integrated OCT

Recent advances have improved the utility of intraoperative visualization, with more innovation on the way.

Bani Aguirre, MD, MPH; Anjali Saini, BS; Vahid Ownagh, MD; and Lejla Vajzovic, MD

April 2026 | Surgical Pearls

Extended ILM Peeling for PVR

This technique can help prevent recurrent retinal detachment by completely removing traction and the scaffold for reproliferation.

Taku Wakabayashi, MD, PhD, and Yoshihiro Yonekawa, MD

April 2026 | Pediatrics

Incontinentia Pigmenti-Associated Retinopathy

Early screening of these patients is imperative for accurate risk assessment and timely intervention.

Sengul Ozdek, MD, FEBO; and Ece Özdemir Zeydanlı, MD, FEBO, FICO

April 2026 | Visually Speaking

A Rare Case of Choroidal Vitiligo

Recognize this uncommon sign of varicella-zoster reactivation.

Tina Tang, MD, and Nauman Chaudhry, MD

View Entire Issue

Popular Articles

March 2026 Insert | One To Watch

One to Watch: Archana A. Nair, MD, MS

Archana A. Nair, MD, MS

April 2026 Insert

One to Watch: Samir N. Patel, MD

Samir N. Patel, MD

March 2026 Supplement | Digital Supplement

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

November/December 2025 Supplement

Preserving Vision in Macular Telangiectasia Type 2

Jay Chhablani, MD, and Lihteh Wu, MD

April 2026 | Features

Imaging Epiretinal Proliferation Using OCT

En face OCT–based identification of proliferative changes may guide surgical strategies in full-thickness macular holes.

Kotaro Tsuboi, MD

Stay updated on the most important business acumen in a concise and easy-to-digest format.

View Resource

Recent Supplements

Understanding Fast Progression in Geographic Atrophy

View Insert

Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence

Editorially Independent Content, Supported With Advertising From Astellas

View Insert

Business Matters: When and How To Hire

Editorially independent content supported with advertising by EyePoint

View Supplement

One to Watch: Samir N. Patel, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Rising Stars in Retina: Prashant D. Tailor, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease

This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.

View Supplement

Featured Authors

Manish Nagpal, MS, FRCS, FASRS

Ahmedabad, India

Racemose Hemangioma An Atlas of Multimodal Imaging in Pediatrics DRIL: A Robust Imaging Biomarker in DME Catching Familial Exudative Vitreoretinopathy Early

Carol L. Shields, MD

Reducing Chemotherapy Duration for High-Risk Retinoblastoma Does Iris Color Matter in Uveal Melanoma? Tissue Glue-Assisted Plaque Radiotherapy for Uveal Melanoma Conditional Survival of Patients With Uveal Melanoma

María H. Berrocal, MD

The New Retina OR: The Latest Vitrectomy Tools Retinectomy for TRD/RRD With PDR and Cataract Your Favorite Secondary IOL Technique Tackle Secondary IOLs With Ease

Eyetube Retina Series

EYETUBE RETINA MEETING COVERAGE

Featured

Complex Myopic MHRD: Membranes and Transplants

April 2026

Popular Articles

Keep in touch

Retina News

Featured Resource